Thr790Met [mutation](English)

• may refer to tyrosine kinase inhibitors and the first-line treatment for patients with EGFR mutant non-small-cell lung cancer
• EGFR, MET, NSCLC, PFS, TKI
• Pulmonology, Oncology, Therapeutic approaches
• https://doi.org….1111/cas.13623
• https://doi.org…7/fon-2021-0356